search
bladder cancer
Trends
- 1Urine RNA test shows promise for bladder cancer detection●Urine cell-free RNA for bladder cancer detection and treatment response prediction
A new study in Nature reports that cell-free RNA found in urine can be used to detect bladder cancer and predict how patients respond to treatment. The liquid biopsy approach could offer a non-invasive alternative to cystoscopy, potentially enabling earlier diagnosis and closer monitoring of therapy response without invasive procedures.
- 2New RNA Urine Test Beats Standard Bladder Cancer Screening●A new RNA urine test outperforms standard bladder cancer tests and could help guide treatment. So get busy whizzing http
A new RNA-based urine test for bladder cancer has reportedly outperformed standard diagnostic tests and may help guide treatment decisions. The test detects molecular markers in urine, offering a non-invasive alternative to invasive procedures. Commenters shared the news enthusiastically, with some joking about the simplicity of providing a sample. The development is being welcomed as a potential step forward in earlier detection and personalized care.
- 3ImmunityBio Shares Post Best Week In Months On Trump Cancer Panel Pick▼IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick
ImmunityBio stock (IBRX) wrapped up its strongest week in more than seven months as retail investors bet its bladder cancer drug Anktiva could benefit from the Trump administration's choice to lead a cancer-focused advisory panel. Traders are speculating the pick could speed adoption or funding for Anktiva, driving renewed buying interest in the biotech.
- 4Urine test may improve bladder cancer diagnosis and treatment▼Urine test may improve bladder cancer diagnosis and guide treatment decisions
Researchers at Stanford Medicine report that a urine test could improve how bladder cancer is diagnosed and help guide treatment decisions. The non-invasive approach may allow doctors to detect the disease and tailor care without more invasive procedures. The announcement is drawing attention as a potential step forward in cancer diagnostics.
- 5Nature Medicine study validates Resero Bio bladder cancer RNA test●Nature Medicine Study Shows Resero Bio's Cell-Free RNA Platform Detects Bladder Cancer and Predicts Treatment Response
A study published in Nature Medicine reports that Resero Bio's cell-free RNA platform can detect bladder cancer and predict how patients respond to treatment. The findings, picked up by financial and science media, suggest the technology could support earlier diagnosis and better-targeted therapy decisions in bladder cancer care, one of the most common and recurrent urological cancers.
- 6Experts Examine Bladder Cancer Care Gaps for Women▼Optimizing Bladder Cancer Care for Women and the Role of Biology and Disparities - Laura Mertens & Niyati Lobo
Researchers Laura Mertens and Niyati Lobo discuss how bladder cancer care for women can be optimized, pointing to biological differences and healthcare disparities that affect diagnosis and treatment outcomes in female patients.
- 7Urine RNA Test Could Detect Bladder Cancer and Predict Response●Urine RNA Test Could Detect Bladder Cancer and Predict Treatment Response
A urine-based RNA test could detect bladder cancer and predict how patients respond to treatment, according to a report from Inside Precision Medicine. If validated, the non-invasive test would offer an alternative to invasive procedures such as cystoscopy and help doctors tailor therapies to individual patients. The finding is drawing attention among clinicians and researchers focused on earlier, less burdensome cancer diagnostics.
- 8Expert highlights sexual health in bladder cancer care▼Armine K. Smith, MD, on addressing sexual health in modern bladder cancer care
Armine K. Smith, MD, is drawing attention to the importance of addressing sexual health in modern bladder cancer care. Speaking in an interview with Urology Times, Smith discussed how sexual health concerns should be incorporated into treatment conversations for bladder cancer patients. The remarks underscore a growing push among urologists to treat quality-of-life issues as a core part of cancer care rather than an afterthought.